Sanofi Hints At Hostile Bid After Genzyme Rejects Offer
Sanofi-Aventis hinted at a hostile takeover Monday after biotechnology company Genzyme Corp. rejected its offer to buy it for $69 a share, or about $18.5 billion, saying the offer failed "to...To view the full article, register now.
Already a subscriber? Click here to view full article